Teladoc Health Financial Statements (TDOC)
|
|
|
|
Report date
|
|
|
28.02.2022 |
01.03.2023 |
23.02.2024 |
27.02.2025 |
26.02.2026 |
|
30.04.2026 |
|
Currency
|
|
|
USD |
USD |
USD |
USD |
USD |
|
USD |
|
Financial report URL
|
|
|
|
|
|
|
|
|
|
|
|
Revenue, bln rub |
? |
|
2 033 |
2 407 |
2 602 |
2 570 |
2 530 |
|
2 514 |
|
Operating Income, bln rub |
|
|
-265.6 |
-13 653 |
-248.6 |
-1 021 |
-263.0 |
|
-191.1 |
|
EBITDA, bln rub |
? |
|
-31.4 |
-7.54 |
43.6 |
31.7 |
147.3 |
|
64.1 |
|
Net profit, bln rub |
? |
|
-428.8 |
-13 660 |
-220.4 |
-1 001 |
-200.3 |
|
-171.1 |
|
|
OCF, bln rub |
? |
|
194.0 |
189.3 |
350.0 |
293.7 |
294.4 |
|
288.0 |
|
CAPEX, bln rub |
? |
|
8.53 |
16.5 |
156.3 |
10.8 |
8.89 |
|
36.9 |
|
FCF, bln rub |
? |
|
185.5 |
172.8 |
193.7 |
282.9 |
285.5 |
|
251.1 |
|
Dividend payout, bln rub
|
|
|
0.000 |
0.000 |
0.000 |
0.000 |
0.000 |
|
0.000 |
|
|
Ordinary share dividend yield, %
|
|
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
|
0.00% |
|
Dividend payout ratio, %
|
|
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
|
0 |
|
|
OPEX, bln rub |
|
|
1 648 |
15 316 |
2 091 |
2 839 |
2 021 |
|
1 841 |
|
Cost of production, bln rub |
|
|
650.3 |
744.0 |
760.0 |
751.3 |
771.6 |
|
864.6 |
|
R&D, bln rub |
|
|
311.9 |
333.6 |
348.5 |
307.3 |
277.9 |
|
320.1 |
|
Interest expenses, bln rub |
|
|
81.1 |
21.9 |
22.3 |
23.8 |
19.7 |
|
19.3 |
|
|
Assets, bln rub |
|
|
17 735 |
4 701 |
4 392 |
3 517 |
3 101 |
|
2 807 |
|
Net Assets, bln rub |
? |
|
16 046 |
2 308 |
2 326 |
1 491 |
1 386 |
|
1 336 |
|
Debt, bln rub |
|
|
1 280 |
1 587 |
1 592 |
1 585 |
1 040 |
|
1 028 |
|
Cash, bln rub |
|
|
896.0 |
918.2 |
1 124 |
1 298 |
781.1 |
|
750.7 |
|
Net debt, bln rub |
|
|
384.1 |
668.7 |
468.6 |
286.3 |
259.1 |
|
276.8 |
|
|
Ordinary share price, rub |
|
|
91.8 |
23.7 |
21.6 |
9.09 |
7.00 |
|
7.04 |
|
Number of ordinary shares, mln |
|
|
156.9 |
161.5 |
162.2 |
170.6 |
176.2 |
|
179.1 |
|
|
Market cap, bln rub |
|
|
14 410 |
3 818 |
3 495 |
1 550 |
1 234 |
|
1 261 |
|
EV, bln rub |
? |
|
14 794 |
4 487 |
3 963 |
1 837 |
1 493 |
|
1 538 |
|
Book value, bln rub |
|
|
-369 |
-602 |
-425 |
-223 |
-195 |
|
-182 |
|
|
EPS, rub |
? |
|
-2.73 |
-84.6 |
-1.36 |
-5.87 |
-1.14 |
|
-0.96 |
|
FCF/share, rub |
|
|
1.18 |
1.07 |
1.19 |
1.66 |
1.62 |
|
1.40 |
|
BV/share, rub |
|
|
-2.35 |
-3.73 |
-2.62 |
-1.31 |
-1.10 |
|
-1.02 |
|
|
EBITDA margin, % |
? |
|
-1.55% |
-0.31% |
1.68% |
1.23% |
5.82% |
|
2.55% |
|
Net margin, % |
? |
|
-21.1% |
-567.5% |
-8.47% |
-39.0% |
-7.92% |
|
-6.81% |
|
FCF yield, % |
? |
|
1.29% |
4.53% |
5.54% |
18.2% |
23.1% |
|
19.9% |
|
ROE, % |
? |
|
-2.67% |
-591.9% |
-9.47% |
-67.1% |
-14.5% |
|
-12.8% |
|
ROA, % |
? |
|
-2.42% |
-290.6% |
-5.02% |
-28.5% |
-6.46% |
|
-6.10% |
|
|
P/E |
? |
|
-33.6 |
-0.28 |
-15.9 |
-1.55 |
-6.16 |
|
-7.37 |
|
P/FCF |
|
|
77.7 |
22.1 |
18.0 |
5.48 |
4.32 |
|
5.02 |
|
P/S |
? |
|
7.09 |
1.59 |
1.34 |
0.60 |
0.49 |
|
0.50 |
|
P/BV |
? |
|
-39.1 |
-6.34 |
-8.22 |
-6.94 |
-6.34 |
|
-6.93 |
|
EV/EBITDA |
? |
|
-470.9 |
-595.4 |
90.9 |
57.9 |
10.1 |
|
24.0 |
|
Debt/EBITDA |
|
|
-12.2 |
-88.7 |
10.7 |
9.02 |
1.76 |
|
4.32 |
|
|
R&D/CAPEX, % |
|
|
3 655% |
2 024% |
222.9% |
2 848% |
3 125% |
|
868.4% |
|
|
CAPEX/Revenue, % |
|
|
0.42% |
0.68% |
6.01% |
0.42% |
0.35% |
|
1.47% |
|
| Teladoc Health shareholders |
